Pfizer Endometriosis Pain Drug Gets OK’d

	Tweet

Pfizer Inc. said on Tuesday it has received U.S. regulatory approval to sell a drug to treat the pain associated with endometriosis, a condition in which tissue from the uterus migrates and implants in other areas of the body.

The injectable drug, depo-subQ provera 104, contains the same active ingredient as the contraceptive Depo-Provera, but in a new formulation.

One of the biggest symptoms of endometriosis is pelvic pain. Pfizer said clinical data shows its drug is as effective in treating pain as Lupron Depot, a common existing treatment, but causes a lower incidence of menopausal symptoms such as hot flashes. 

RELATED STORIES:
FDA Says None of Chiron Influenza Vaccine Safe for Use   Takeda may extend sleeping pill’s use for AD   FDA approves Azilect for the treatment of Parkinson’s   Cialis could top Viagra sales by 2006   Anti-inflammatory Drugs May Do More Harm than Good in Tendinopathy   Anti-parasite drugs effective in mothers, children   Parkinson’s Drugs Tradeoff: Better Muscle Control, Worse Side Effects   Viagra safe with blood pressure drugs, study shows   Painkiller Vioxx Often Taken at Too High Dose   ‘Da Vinci Diet’ Digs Carbs   Rasagiline improves movement in Parkinson’s   FDA Approves New Insomnia Drug

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]